We are live on ! Find out more
MCI

McDonald Capital Investors Portfolio holdings

AUM $1.37B
1-Year Est. Return 1.88%
This Fund
S&P 500
This Quarter Est. Return
-0.56%
1 Year Est. Return
-1.88%
3 Year Est. Return
+60.24%
5 Year Est. Return
+91.56%
10 Year Est. Return
+335.97%
AUM
$1.13B
AUM Growth
-$72.7M
Cap. Flow
-$52.3M
Cap. Flow %
-4.65%
Top 10 Hldgs %
79.78%
Holding
27
New
2
Increased
2
Reduced
15
Closed
5

Top Sells

Rank Stock Value
1
PAYX icon
Paychex
PAYX
+$30.5M
2
PGR icon
Progressive
PGR
+$11.1M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.96M
4
WFC icon
Wells Fargo
WFC
+$1.24M
5
BN icon
Brookfield
BN
+$1.1M

Sector Composition

Rank Sector Weight
1 Financials 39.47%
2 Healthcare 15.9%
3 Communication Services 12.16%
4 Technology 10.51%
5 Industrials 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRRA
26
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-6,600
Closed -$363K
BHVN
27
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-5,125
Closed -$747K

Similar funds

McDonald Capital Investors's Q3 2022 Portfolio in Review

As of Q3 2022, McDonald Capital Investors held 27 positions worth $1.13B, down 6.1% from $1.2B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

McDonald Capital Investors withdrew a net $52.3M in Q3 2022, closing 5 positions and reducing 15 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $747K position sold in full.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 39% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, McDonald Capital Investors opened a new position in ChemoCentryx, Inc. worth $1.35M.

  • McDonald Capital Investors's largest Q3 2022 buy was ChemoCentryx, Inc.: 26,100 shares worth $1.35M.
  • McDonald Capital Investors added most to JPMorgan Chase in Q3 2022, an estimated $699K increase.
  • McDonald Capital Investors's biggest Q3 2022 reduction was Paychex, cutting an estimated $30.5M.
  • McDonald Capital Investors fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $747K.
  • McDonald Capital Investors's ten largest holdings make up 80% of its $1.13B portfolio in Q3 2022.
  • McDonald Capital Investors opened 2 new positions and closed 5 in Q3 2022.
  • McDonald Capital Investors's portfolio value fell 6.1% quarter-over-quarter to $1.13B.

Based on McDonald Capital Investors's 13F filing for Q3 2022, filed 4 Nov 2022.